Right after the FDA flagged safety concerns for Eli Lilly's newly approved obesity pill, the pharma posted diabetes data demonstrating a clean safety profile and revealed plans to seek approval in the
pharminent
April 16, 2026 (Last updated: April 16, 2026)
BioSpace
Right after the FDA flagged safety concerns for Eli Lilly’s newly approved obesity pill, the pharma posted diabetes data demonstrating a clean safety profile and revealed plans to seek approval in the
